¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"adenosine 5'-phosphoramidate hydrolase"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hydrolase
    °¡¼öºÐÇØÈ¿¼Ò
  • adenosine
    ¾Æµ¥³ë½Å
  • adenosine deaminase
    ¾Æµ¥³ë½ÅÅ»¾Æ¹Ì³ëÈ¿¼Ò
  • cyclic adenosine monophosphate
    °í¸®ÇüAMP
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adenosine
    ¾Æµ¥³ë½Å
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adenosine
    ¾Æµ¥³ë½Å
  • cyclic adenosine monophosphate
    °í¸®¿¡ÀÌ¿¥ÇÇ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Glycerol ester hydrolase
    ±Û¸®¼¼·Ñ ¿¡½ºÅÍ °¡¼öºÐÇØÈ¿¼Ò(Ê¥â©ÝÂú°ý£áÈ)
  • aspartylglycosamine amide hydrolase, deficiency
    Aspartylglycosamine amide hydrolase°áÇÌ(¡­ÌÀù¹)
  • hydrolase
    ÇÏÀ̵å·Ñ·¹À̽º, Hydrolase
  • ADP=£¾adenosine diphosphate
    ¾Æµ¥³ë½ÅÀÌÀλê.
  • ATP => adenosine triphosphate
    »ïÀÎ»ê¾Æµ¥³ë½Å
  • ATP=> adenosine triphosphate
    ¾Æµ¥³ë½Å »ïÀλê
  • ATP=£¾adenosine triphosphate
    ¾Æµ¥³ë½Å»ïÀλê.
  • adenosine
    ¾Æµ¥³ë½Å
  • adenosine 5-monophosphate
    ¾Æµ¥³ë½Å 5-ÀÏÀλ꿰
  • adenosine deaminase
    ¾Æµ¥³ë½Å, µð¾Æ¹Ì³ªÁ¦ <Å»¾Æ¹Ì³ëÈ¿¼Ò>.
  • adenosine deaminase
    ¾Æµ¥³ë½Åµ¥¾Æ¹Ì³ªÁ¦<--Å»¾Æ¹Ì³ëÈ¿¼Ò>
  • adenosine deaminase(ada)
    ¾Æµ¥³ë½Å µð¾Æ¹Ì³×À̽º
  • adenosine diphosphate
    ÀÌÀÎ»ê¾Æµ¥³ë½Å
  • adenosine diphosphate =ADP
    ÀÌÀÎ»ê¾Æµ¥³ë½Å.
  • adenosine diphosphate(adp)
    ¾Æµ¥³ë½ÅÀÌÀλê(¡­ì£ìÝß«)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspartylglycosamine amide hydrolase, deficiency
    Aspartylglycosamine amide hydrolase°áÇÌ(¡­ÌÀù¹)
  • hydrolase
    ÇÏÀ̵å·Ñ·¹À̽º, Hydrolase
  • peptidyldipeptide hydrolase
    ÆéƼµôµðÆéƼµåÈ÷µå·Ñ¶óÁ¦
  • adenosine
    ¾Æµ¥³ë½Å
  • adenosine 5-monophosphate
    ¾Æµ¥³ë½Å 5-ÀÏÀλ꿰
  • adenosine deaminase
    ¾Æµ¥³ë½Åµ¥¾Æ¹Ì³ªÁ¦<--Å»¾Æ¹Ì³ëÈ¿¼Ò>
  • adenosine deaminase
    ¾Æµ¥³ë½Å, µð¾Æ¹Ì³ªÁ¦ <Å»¾Æ¹Ì³ëÈ¿¼Ò>.
  • adenosine deaminase(ada)
    ¾Æµ¥³ë½Å µð¾Æ¹Ì³×À̽º
  • adenosine diphosphate
    ÀÌÀÎ»ê¾Æµ¥³ë½Å
  • adenosine diphosphate =ADP
    ÀÌÀÎ»ê¾Æµ¥³ë½Å.
  • adenosine diphosphate(adp)
    ¾Æµ¥³ë½ÅÀÌÀλê(¡­ì£ìÝß«)
  • adenosine monophosphate
    ÀÏÀÎ»ê¾Æµ¥³ë½Å
  • adenosine monophosphate =AMP
    ÀÏÀÎ»ê¾Æµ¥³ë½Å.
  • adenosine triphosphatase
    ¾Æµ¥³ë½Å »ïÀλêÈ¿¼Ò
  • adenosine triphosphatase
    ¾Æµ¥³ë½Å Æ®¸®Æ÷½ºÆÄÅ×À̽º
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phosphoramidate
    Æ÷½ºÆ÷¶ó¹Ìµå»ê¿°(ß«ç¤)
  • alkaline hydrolase
    ¾ËÄ®¸®¼º ÇÏÀ̵å·Ñ·¹À̽º
  • hydrolase
    ÇÏÀ̵å·Ñ·¹À̽º
  • adenosine
    ¾Æµ¥³ë½Å
  • adenosine deaminase
    ¾Æµ¥³ë½Åµð¾Æ¹Ì³×À̽º
  • adenosine diphosphate
    ÀÌÀλê(ì£ìÝß«)¾Æµ¥³ë½Å
  • adenosine diphosphate glucose
    ÀÌÀλê(ì£ìÝß«)¾Æµ¥³ë½Å ±Û·çÄÚ½º
  • adenosine monophosphate
    ÀÏÀλê(ìéìÝß«)¾Æµ¥³ë½Å
  • adenosine triphosphatase
    ¾Æµ¥³ë½Å Æ®¸®Æ÷½ºÆÄÅ×À̽º
  • adenosine triphosphate
    »ïÀλê(ß²ìÝß« )¾Æµ¥³ë½Å
  • "adenosine-3',5'-cyclic monophosphate"
    ¾Æµ¥³ë½Å-3'-5'-°í¸® ÀÏ(ìé)Àλ꿰(×òß«ç¤)
  • adenosine-5'-phosphosulfate
    ¾Æµ¥³ë½Å-5'-ÀÎȲ»ê¿°(ìÝüÜß«ç¤)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CAMP Christie-Atkins-Munch-Petersen [test]; computer-assisted menu planning; concentration of adenosine m...
ACEH acid cholesterol ester hydrolase
CEH cholesterol ester hydrolase
DPH Department of Public Health; diphenhydramine; diphenylhexatriene; diphenylhydantoin; Diploma in Publ...
FGH formylglutathione hydrolase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BH Bleomycin hydrolase
CEH Cholesterol ester hydrolase
cEH Cytosolic epoxide hydrolase
EH Epoxide hydrolase
FAAH Fatty acid amide hydrolase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hydrolase
    °¡¼öºÐÇØ È¿¼Ò, ÇÏÀ̵å·Ñ·¹À̽º
    ¿¡½ºÅÍ, ÆéŸÀ̵å, ±Û¶óÀÌÄÚ»çÀÌµå ¹× ¾Æ¸¶À̵å¿Í °°Àº È­ÇÕ¹°ÀÇ °¡¼öºÐÇØ¸¦ Ã˸ÅÇÏ´Â 6´ë È¿¼Ò±ºÀÇ ÀÏÁ¾.
  • adenosine
    ¾Æµ¥³ë½Å
    ´ºÅ¬·¹¿À»çÀ̵å, ¾Æµ¥´Ñ D ¸®º¸½º, Çٻ꿡¼­ À¯µµµÈ´Ù. ¾Æµ¥´Ñ¿¡ D-¸®º¸¿À½º°¡ °áÇÕÇÑ ´ºÅ¬·¹¿ÀƼµå. ¹é»öÀÇ Ä§»ó °áÁ¤À̸ç, ³ì´Â Á¡ 235 ¡ÉÀÌ´Ù. ¹°¿¡´Â Àß ³ìÀ¸³ª, ¾ËÄڿÿ¡´Â °ÅÀÇ ³ìÁö ¾Ê´Â´Ù. RNA
  • adenosine 5-monophosphate
    ¾Æµ¥³ë½Å 5-ÀÏÀλ꿰
  • adenosine deficiency
    ¾Æµ¥³ë½Å °áÇÌÁõ
  • adenosine kinase
    ¾Æµ¥³ë½Å Ä«À̳×À̽º
    ATP+adenosine=ADP+AMPÀÇ È­ÇйÝÀÀÀ» Ã˸ÅÇÏ´Â ÀüÀÌÈ¿¼ÒÀÇ ÇϳªÀÌ´Ù. ÀÌ ¹ÝÀÀÀº
  • adenosine monophosphate
    ¾Æµ¥³ë½Å ÀÏ Àλê, ÀÏÀÎ»ê ¾Æµ¥³ë½Å
    ¾Æµ¥´Ñ°ú ¸®º¸½ºÀÇ °áÇÕ¹°ÀÎ ¾Æµ¥³ë½Å¿¡ ÀλêÀÌ ¿¡½ºÅ׸£ °áÇÕÇÑ ¸ð³ë´ºÅ¬·¹¿ÀŸÀ̵åÀÇ ÀÏÁ¾. ÀλêÈ­µÇ¾î °í¿¡³ÊÁö È­ÇÕ¹°ÀÎ ¾Æµ¥³ë½Å 2Àλê, 3ÀλêÀÌ »ý±ä´Ù. ÀλêÀÌ ¸®º¸½ºÀÇ C5 Å͹̳¯¿¡ °áÇÕÇÑ °Í°ú C3 Å͹̳¯¿¡ °áÇÕÇÑ 2Á¾ÀÇ À̼ºÃ¼°¡ Á¸ÀçÇϰí ÀüÀÚ´Â ±ÙÀ° µî¿¡¼­ º¼ ¼ö ÀÖÀ¸¸ç, ÈÄÀÚ´Â È¿¸ð ÇÙ»êÀÇ °¡¼öºÐÇØ µîÀ¸·Î ¾ò°Ô µÈ´Ù. ¾çÀÚ°¡ ¸ðµÎ ¹°¿¡ Àß ³ìÁö ¾Ê´Â ħ»ó °áÁ¤ÀÌ´Ù.
  • adenosine triphosphate
    ¾Æµ¥³ë½Å »ïÀλê, »ïÀÎ»ê ¾Æµ¥³ë½Å, ¾Æµ¥³ë½Å Æ÷½ºÆÄŸÁ¦
    ¾Æµ¥´Ñ¿¡ ¸®º¸½º°¡ °áÇÕÇÑ È­ÇÕ¹° ¾Æµ¥³ë½Å¿¡ 3ºÐÀÚÀÎ ÀλêÀÌ ¸®º¸½ºÀÇ 5Å͹̳¯ À§Ä¡¿¡ °áÇÕÇÑ °Í. 3ºÐÀÚÀÎ ÀÎ»ê °¡¿îµ¥ °¡Àå ³ªÁßÀÇ °ÍÀº À̸¥¹Ù °í¿¡³ÊÁö °áÇÕÀ¸·Î °áÇÕÇϰí ÀÖÀ¸¸ç ÀÌ °áÇÕÀÌ ¶³¾îÁ® ADP¿Í ¹«±âÀλêÀ¸·Î °¡¼öºÐÇØÇÏ¸é ¸ô´ç 7.4kcalÀÇ ¿¡³ÊÁö°¡ ¹æÃâµÈ´Ù. ÀÌ ¿¡³ÊÁö´Â ±ÙÀ°ÀÇ ¿îµ¿, ½Å°æÀÇ Àüµµ, °íºÐÀÚ È­ÇÕ¹°ÀÇ ÇÕ¼º µî »ýü³»ÀÇ ¿¡³ÊÁö¿øÀÌ µÈ´Ù.
  • nucleotide adenosine triphosphate
    ´ºÅ¬·¹¿ÀƼµå ¾Æµ¥³ë½Å Æ®¸®Æ÷½ºÆäÀÌÆ®
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
adenosine 5'-phosphoramidate hydrolase <enzyme> Hydrolyzes nucleoside 5'-monophosphoramidates into nucleoside 5'-phosphates and ammonia
Registry number: EC 3.9.1.-
Synonym: ampn hydrolase, nucleoside monophosphoramidate hydrolase
(26 Jun 1999)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
adenosine <biochemistry> A ribonucleotide which consists of the nitrogenous base adenine linked to the sugar ribose.
<drug> A cardiac drug used in terminating PSVT involving reentry pathways that include the AV node or Wolff-Parkinson-White syndrome. For atrial flutter, atrial fibrillation, atrial or ventricular tachycardias, adenosine may produce transient AV block that may help identify the rhythm.
Pharmacologic action: Endogenous purine nucleoside that depresses AV node and sinus node activity. Brief duration of action (1-2 min).
Dose: Rapid 6 mg IV bolus over 1-3 sec. May repeat at 12 mg IV bolus within 1-2 min Patients taking theophylline may require larger doses. Use a smaller dose with cardiac transplant patients.
Potential complications: Common but transient - flushing, dyspnea, chest pain, bradycardia, and ventricular ectopy. Theophylline (and caffeine) blocks adenosine's effects. Dipyridamole potentiates adenosine's effects. Use other agents to avoid these drug interactions.
(15 Mar 2000)
adenosine 3',5'-cyclic monophosphate An activator of phosphorylase kinase and an effector of other enzymes, formed in muscle from ATP by adenylate cyclase and broken down to 5'-AMP by a phosphodiesterase; sometimes referred to as the "second messenger." A related compound (2',3') is also known.
Synonym: cyclic adenylic acid, cyclic AMP, cyclic phosphate.
Acronym: cAMP
(05 Mar 2000)
adenosine 3',5'-cyclic phosphate phosphodiesterase <enzyme> An enzyme that catalyses the hydrolysis of adenosine 3',5'-cyclic phosphate forming 5'-AMP. A crucial step in the regulation of cellular adenosine 3',5'-cyclic phosphate levels. Inhibited by caffeine.
Synonym: cAMP phosphodiesterase.
(05 Mar 2000)
adenosine 3'-phosphate 3'-Adenylic acid.
See: adenylic acid.
(05 Mar 2000)
adenosine 3'-phosphate 5'-phosphosulfate 3'-phosphoadenosine 5'-phosphosulfate;an intermediate in the formation of urinary ethereal sulfates, notable for containing a "high energy" sulfate bond; the 3'-OH of adenosine is replaced by -OPO3H2, the 5'-OH by -OP(O2H)-OSO3H.
Synonym: active sulfate.
Acronym: PAPS
(05 Mar 2000)
adenosine 5'-diphosphate A condensation product of adenosine with pyrophosphoric acid, formed from ATP by the hydrolysis of the terminal phosphate group of the latter compound.
Acronym: ADP
(05 Mar 2000)
adenosine-5'-(n-ethylcarboxamide) <chemical> A stable adenosine a1 and a2 receptor agonist. Experimentally, it inhibits camp and cgmp phosphodiesterase activity.
Pharmacological action: antineoplastic agent, vasodilator agents.
(12 Dec 1998)
adenosine 5'-phosphate 5'-Adenylic acid.
See: adenylic acid.
(05 Mar 2000)
adenosine 5'-phosphosulfate An intermediate in the formation of PAPS (active sulfate).
Adenosine 5'-phosphosulfate kinase, the enzyme that catalyses the formation of active sulfate from adenosine 5'-phosphosulfate and ATP.
Acronym: APS
(05 Mar 2000)
adenosine 5'-phosphosulfate sulfotransferase <enzyme> Catalyses transfer of sulfo group of adenylylsulfate to a carrier organic thiol, forming carrier-bound thiosulfate and AMP
Registry number: EC 2.8.2.-
Synonym: apsstase, aps sulfotransferase, adenylylsulfate sulfotransferase
(26 Jun 1999)
adenosine 5'-triphosphate Adenosinepyrophosphate;adenosine with triphosphoric acid esterfied at its 5' position; immediate precursors of adenine nucleotides in RNA. The primary energy currency of a cell.
Synonym: adenosine triphosphate.
Acronym: ATP
(05 Mar 2000)
adenosine cyclic phosphate An activator of phosphorylase kinase and an effector of other enzymes, formed in muscle from ATP by adenylate cyclase and broken down to 5'-AMP by a phosphodiesterase; sometimes referred to as the "second messenger." A related compound (2',3') is also known.
Synonym: cyclic adenylic acid, cyclic AMP, cyclic phosphate.
Acronym: cAMP
(05 Mar 2000)
adenosine deaminase <enzyme> An enzyme that catalyses the hydrolysis of adenosine to inosine with the elimination of ammonia. Since there are wide tissue and species variations in the enzyme, it has been used as a tool in the study of human and animal genetics and in medical diagnosis.
Chemical name: Adenosine aminohydrolase
Registry number: EC 3.5.4.4
(12 Dec 1998)
adenosine diphosphate <biochemistry> ADP is used as an adenine, a ribose and a diphosphate unit.
(06 May 1997)
adenosine diphosphate glucose <chemical> Serves as the glycosyl donor for formation of bacterial glycogen, amylose in green algae, and amylopectin in higher plants.
Chemical name: Adenosine 5'-(trihydrogen diphosphate), P'-alpha-D-glucopyranosyl ester
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adenosine
    ¾Æµ¥³ë½Å;¸®º¸ÇÙ»êÀÇ È¿¼ÒºÐÇØ¿¡ ÀÇÇÏ¿© ¾ò¾îÁü I
  • cyclic adenosine monophosphate
    =CYCLIC AMP
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á